» Articles » PMID: 17622951

Molecular Analysis of Patients with Type III Bartter Syndrome: Picking Up Large Heterozygous Deletions with Semiquantitative PCR

Abstract

Type III Bartter syndrome (BS) (OMIM607364) is caused by mutations in the basolateral chloride channel CIC-Kb gene (CLCNKB). The CLCNKB gene is sometimes reported as having a large deletion mutation, but all cases reported previously were large homozygous deletions and a large heterozygous deletion is impossible to detect by direct sequencing. This report concerns a genetic analysis of five Japanese patients with type III BS. To identify the mutations, we used polymerase chain reaction (PCR) and direct sequencing. To detect large heterozygous deletion mutations of the CLCNKB gene, we conducted semiquantitative PCR amplification using capillary electrophoresis. The result was that four mutations were identified, comprising one novel 2-bp deletion mutation, an entire heterozygous deletion, and a heterozygous deletion mutation of exons 1 and 2. The nonsense mutation W610X was detected in all patients, and this mutation is likely to constitute a founder effect in Japan. Capillary electrophoresis is a new method and extremely useful for detecting large heterozygous deletions, and should be used to examine type III BS cases in whom only a heterozygous mutation has been detected by direct sequencing. This is the first report to identify large heterozygous deletion mutations in the CLCNKB gene in patients with type III BS.

Citing Articles

Long-read sequencing identifies a common transposition haplotype predisposing for CLCNKB deletions.

Tschernoster N, Erger F, Kohl S, Reusch B, Wenzel A, Walsh S Genome Med. 2023; 15(1):62.

PMID: 37612755 PMC: 10464140. DOI: 10.1186/s13073-023-01215-1.


Clinical and genetic approach to renal hypomagnesemia.

Tseng M, Konrad M, Ding J, Lin S Biomed J. 2021; 45(1):74-87.

PMID: 34767995 PMC: 9133307. DOI: 10.1016/j.bj.2021.11.002.


Historical and geographical distribution of the founder mutation c.610G>A; p.Ala204Thr in the gene linked to Bartter syndrome type III in Spain.

Peces R, Mena R, Peces C, Barruz P, Trujillo H, Carreno A Clin Kidney J. 2021; 14(8):1990-1993.

PMID: 34345425 PMC: 8323134. DOI: 10.1093/ckj/sfab083.


Targeted broad-based genetic testing by next-generation sequencing informs diagnosis and facilitates management in patients with kidney diseases.

Mansilla M, Sompallae R, Nishimura C, Kwitek A, Kimble M, Freese M Nephrol Dial Transplant. 2019; 36(2):295-305.

PMID: 31738409 PMC: 7834596. DOI: 10.1093/ndt/gfz173.


Detection of copy number variations by pair analysis using next-generation sequencing data in inherited kidney diseases.

Nagano C, Nozu K, Morisada N, Yazawa M, Ichikawa D, Numasawa K Clin Exp Nephrol. 2018; 22(4):881-888.

PMID: 29372472 DOI: 10.1007/s10157-018-1534-x.